EmployblEmploybl logo
employbl
EGenesis logo

EGenesis Funding & Investors

Cambridge, MA

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.

egenesisbio.com

Total Amount Raised: $456,000,000

EGenesis Funding Rounds

  • Series D

    $191,000,000

    Series D Investors

    Lux Capital
    Farallon Capital Management
    Alta Partners
    Arch Venture Partners
    Khosla Ventures
    Leaps by Bayer
    Natco Pharma
    DaVita
    Fresenius Medical Care
    Parkwood
    Eisai Innovation

  • Series C

    $125,000,000

    Series C Investors

    Irving Investors
    LifeSci Venture Partners
    Monashee Investment Management
    Osage University Partners II
    Farallon Capital Management
    Altium Capital
    Samsara BioCapital
    Symbiosis
    Polaris Partners
    HBM Healthcare Investments
    Fresenius Medical Care
    Leaps by Bayer
    Khosla Ventures
    Wellington Partners
    Catalio Capital Management
    Arch Venture Partners
    Invus
    Alta Partners

  • Series B

    $100,000,000

    Series B Investors

    Fresenius Medical Care
    Khosla Ventures
    Biomatics Capital Partners
    Wellington Partners
    Leaps by Bayer
    Alta Partners
    Arch Venture Partners

  • Series A

    $38,000,000

    Series A Investors

    Arch Venture Partners
    Biomatics Capital Partners
    Khosla Ventures
    Alta Partners
    Alexandria Venture Investments
    Heritage Provider Network
    Berggruen Holdings
    Uprising
    Fan Ventures
    JDRF T1D Fund
    E Squared Capital Management

  • Convertible Note

    $2,000,000

Funding info provided by Diffbot.